7SSK
Human P300 complexed with a glycine-based inhibitor
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 22-BM |
| Synchrotron site | APS |
| Beamline | 22-BM |
| Temperature [K] | 93 |
| Detector technology | CCD |
| Collection date | 2018-02-13 |
| Detector | RAYONIX MX300-HS |
| Wavelength(s) | 1 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 63.878, 48.772, 109.353 |
| Unit cell angles | 90.00, 101.18, 90.00 |
Refinement procedure
| Resolution | 44.440 - 2.360 |
| R-factor | 0.189 |
| Rwork | 0.187 |
| R-free | 0.23500 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 3biy |
| RMSD bond length | 0.009 |
| RMSD bond angle | 1.554 |
| Data reduction software | HKL-2000 |
| Data scaling software | SCALEPACK |
| Phasing software | MOLREP |
| Refinement software | REFMAC (5.8.0267) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 100.000 | 100.000 | 2.390 |
| High resolution limit [Å] | 2.350 | 6.380 | 2.350 |
| Rmerge | 0.109 | 0.072 | 0.587 |
| Rmeas | 0.128 | 0.085 | 0.693 |
| Rpim | 0.066 | 0.044 | 0.366 |
| Total number of observations | 93875 | ||
| Number of reflections | 26521 | 1416 | 1271 |
| <I/σ(I)> | 8.3 | ||
| Completeness [%] | 99.1 | 99.4 | 98.4 |
| Redundancy | 3.5 | 3.5 | 3.3 |
| CC(1/2) | 0.986 | 0.740 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION | 6.5 | 277 | 20% PEG3350, 0.1 M MES pH 6.5 |
